Key regions: Australia, Italy, France, South Korea, Brazil
Haiti, a Caribbean country with a population of over 11 million, has been facing various health challenges, including vaccine-preventable diseases. The vaccines market in Haiti has been developing in response to these challenges and the efforts of the government and international organizations to improve the country's healthcare system.
Customer preferences: Haiti has a high burden of vaccine-preventable diseases such as measles, polio, and cholera. As a result, the demand for vaccines is high, especially among children and vulnerable populations. However, there is still a need for more awareness and education on the importance of vaccination in the country.
Trends in the market: The vaccines market in Haiti has been growing in recent years due to the efforts of the government and international organizations to improve the country's healthcare system. The introduction of new vaccines, such as the HPV vaccine, has also contributed to the growth of the market. However, there are still challenges in vaccine distribution and accessibility, particularly in rural areas.
Local special circumstances: Haiti has been facing various challenges in its healthcare system, including a shortage of healthcare workers, inadequate infrastructure, and limited funding. These challenges have affected the distribution and accessibility of vaccines in the country, particularly in rural areas. The country has also been facing political instability, which has further affected its healthcare system.
Underlying macroeconomic factors: Haiti is one of the poorest countries in the Western Hemisphere, with a GDP per capita of less than $900. The country has been heavily reliant on foreign aid and loans, which has affected its healthcare system. The government has been working to improve the country's healthcare system, but there is still a need for more investment in healthcare infrastructure and human resources. The COVID-19 pandemic has also affected the country's healthcare system and vaccine distribution efforts.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
